DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $575,000 | -88.2% | 18,725 | -80.7% | 0.00% | -83.3% |
| Q3 2021 | $4,887,000 | -0.0% | 96,868 | +13.2% | 0.01% | -14.3% |
| Q1 2021 | $4,888,000 | -55.1% | 85,607 | -34.1% | 0.01% | -53.3% |
| Q4 2020 | $10,875,000 | +447.0% | 129,839 | +134.1% | 0.02% | +400.0% |
| Q3 2020 | $1,988,000 | +243.4% | 55,471 | +66.9% | 0.00% | +200.0% |
| Q4 2019 | $579,000 | -50.5% | 33,242 | -34.0% | 0.00% | -66.7% |
| Q1 2019 | $1,169,000 | – | 50,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |